Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer

Journal:

Nature Communications

Published:

2025-12-17

DOI:

10.1038/s41467-025-67298-z

Affiliations:

28

Authors:

32

Go to article

Institutions	Authors	Share
UH Seidman Cancer Center, CWRU, United States of America (USA)	8.000000	0.25
The Ottawa Hospital (TOH), Canada	3.000000	0.09
Huntsman Cancer Institute at the University of Utah (HCI), Utah, United States of America (USA)	2.000000	0.06
Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Australia	2.000000	0.06
Case Comprehensive Cancer Center (Case CCC), United States of America (USA)	1.000000	0.03
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, United States of America (USA)	1.000000	0.03
Institute Gustave-Roussy (IGR), France	1.000000	0.03
Duke University Health System, United States of America (USA)	1.000000	0.03
University Hospital Saint-Luc, Belgium	1.000000	0.03
Princess Margaret Cancer Centre, U of T, Canada	1.000000	0.03
University of California, Los Angeles (UCLA), United States of America (USA)	1.000000	0.03
Moores Cancer Center, United States of America (USA)	1.000000	0.03
UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC), United States of America (USA)	1.000000	0.03
START Carolinas, United States of America (USA)	1.000000	0.03
Hospital of the University of Montreal (CHUM), Canada	1.000000	0.03
The University of Adelaide (Adelaide Uni), Australia	1.000000	0.03
The University of Sydney (USYD), Australia	0.666667	0.02
National Health and Medical Research Council (NHMRC), Australia	0.666667	0.02
Vancouver Prostate Centre (VPC), Canada	0.500000	0.02
BC Cancer Agency (BCCA), PHSA, Canada	0.500000	0.02
Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK)	0.500000	0.02
Sarah Cannon Research Institute - UK, United Kingdom (UK)	0.500000	0.02
Mount Sinai Hospital (MSH), U of T, Canada	0.500000	0.02
University Health Network (UHN), U of T, Canada	0.500000	0.02
Eastern Health, Australia	0.333333	0.01
Moorabbin Hospital, Monash Health, Australia	0.333333	0.01

Interested in Oncology and Carcinogenesis?